# CareOS Module 5 completion report

**Module:** M5 Encounters and episodes (`P5-01` through `P5-12`)  
**Repository construction status:** complete and module-focused verification passed  
**Verification date:** 26 September 2026  
**Consolidated QA:** deferred under `PROJECT-STANDING-DIRECTION-20260926-01`  
**Production status:** not approved; clinical-owner policy and target-environment activation remain separate

## Completed scope

- V83 releases the migration-owned encounter permissions, operations and high-assurance signing/amendment requirements. V84 adds the 14-relation encounter model. V85 adds payload-minimized audit/outbox contracts and direct lifecycle guards. V86-V89 harden append-only clinical assertions, participant/status identity, red-flag evidence, cross-table authorship and dependency-free SHA-256 note/amendment binding through forward-only repairs.
- `P5-01` through `P5-12` now use checked tenant-authorized projections and governed actions for the encounter dashboard, encounter opening, patient/appointment context, lifecycle, participants, presenting concerns, clinical timeline, problems/diagnoses, orders/tasks, notes, signing, amendments and history.
- Encounter lifecycle is explicit and revision-bound. A confirmed appointment is optional provenance only and cannot implicitly open, start, complete or sign an encounter.
- Practitioner participants retain immutable identity, role, assignment and point-in-time eligibility snapshots. Signing requires the authenticated actor to resolve to the eligible practitioner participant; application access alone is insufficient.
- Notes are append-only versions. Signatures bind the exact current version and digest. Corrections append an attributed amendment to the exact signed version and never rewrite prior clinical content.
- Recording a red flag atomically creates a critical task and escalation. Completion remains blocked until the escalation is explicitly acknowledged and resolved with attributed evidence.
- Audit, outbox and history projections contain identifiers, states, digests and policy references rather than raw concern, diagnosis, order, task, note or amendment text.
- External terminology validation, order fulfilment, laboratory/imaging delivery, specialty templates, local red-flag catalogues/SLAs and legal attestation wording remain explicit activation inputs rather than fabricated repository behavior.

## Repository evidence

| Gate | Result | Evidence |
| --- | --- | --- |
| Backend compilation and encounter verification | PASS | Java 25/Maven 3.9.11 compiles 407 production and 40 test sources. The focused catalogue/registry/lifecycle run applies all V1-V89 migrations to disposable PostgreSQL 18 and passes 5/5 tests, including the complete governed encounter lifecycle and direct rewrite rejection. |
| Encounter lifecycle and safety | PASS | The integration path exercises opening, arrival/start/hold/resume, participants, red-flag task/escalation acknowledgement and resolution, problems, diagnoses, orders, tasks, two note versions, signing, completion, post-completion amendment, history, audit/outbox counts and direct-SQL immutability rejection. |
| API and generated client | PASS | OpenAPI 3.1 version 0.44.0 verifies exactly 116 operations; generated TypeScript has no drift and all 20 positive/negative API-contract cases pass. |
| Frontend static/unit/build | PASS | Formatting, strict typecheck, lint, the 39-source/6-feature/107-import boundary plus four negative fixtures, all 96 unit tests and the production build pass. |
| Module 5 browser/accessibility/responsive | PASS | All 12 P5 routes plus the governed P5-09 note-version flow pass in 10 Playwright cases across exact 1440, 1024, 768, 390 and 320 projects, including Axe and document-overflow checks. |
| Public catalogue | PASS | The public registry now reports 122 screens: M1 23, M2 29, M3 16, M4 15, M5 12 and COS 27. |

## Deferred QA and activation

The requested consolidated cross-module QA, full browser regression, image/deployment/security reruns and target-environment acceptance remain deferred until repository construction is complete. This report does not approve clinical content policy or production use. QA findings must be applied through forward changes; already-applied migrations remain immutable.

Production activation still requires accountable clinical ownership, local terminology and red-flag policy, escalation timing/notification ownership, attestation wording, provider contracts, practitioner and service catalogues, worker identities, monitoring, backup/restore, deployment evidence and operational sign-off.

## Next dependency

Module 6 Clinical Assessment may consume the governed encounter, participant and signed-document boundaries. The retained COS routes are not accepted clinical source assets; where exact protected assets or local clinical policy are unavailable, M6 must preserve an explicit safe boundary and continue with independently implementable structure under the standing direction.
